HYTN Innovations Inc. announced that its wholly owned subsidiary, HYTN Cannabis Inc., has been awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers. National sales of HYTN's cannabis-infused sparkling beverages had already begun through a partnership agreement with Emerald Health Therapeutics Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 CAD | +5.26% | +20.00% | +328.57% |
26/03 | HYTN Innovations Inc. announced that it has received CAD 0.74855 million in funding | CI |
29/02 | HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+328.57% | 1.61Cr | |
+50.24% | 62TCr | |
+5.21% | 27TCr | |
+2.61% | 4.61TCr | |
+21.13% | 2.34TCr | |
+74.52% | 2.14TCr | |
-12.04% | 1.68TCr | |
+20.69% | 1.28TCr | |
+4.16% | 1.15TCr | |
+22.13% | 1.1TCr |
- Stock Market
- Equities
- HYTN Stock
- News HYTN Innovations Inc.
- HYTN Innovations Inc. Announces its Wholly Owned Subsidiary, HYTN Cannabis Inc. Receives Approval for the Sale of Cannabis to Provincially and Territorially Authorized Retailers